These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32496938)

  • 1. A case report of serious haemolysis in a glucose-6-phosphate dehydrogenase-deficient COVID-19 patient receiving hydroxychloroquine.
    Maillart E; Leemans S; Van Noten H; Vandergraesen T; Mahadeb B; Salaouatchi MT; De Bels D; Clevenbergh P
    Infect Dis (Lond); 2020 Sep; 52(9):659-661. PubMed ID: 32496938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose-6-phosphate dehydrogenase deficiency.
    Beauverd Y; Adam Y; Assouline B; Samii K
    Eur J Haematol; 2020 Sep; 105(3):357-359. PubMed ID: 32324284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial.
    Bosaeed M; Mahmoud E; Hussein M; Alharbi A; Alsaedy A; Alothman A; Aljeraisy M; Alqahtani H; Nashabat M; Almutairi B; Almaghaslah M; Aldibasi O; AlJohani S; Bouchama A; Arabi Y; Alaskar A
    Trials; 2020 Oct; 21(1):904. PubMed ID: 33129363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linking hydroxychloroquine to hemolysis in a 'suspected' glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection - a critical appraisal.
    Afra TP; Nampoothiri RV; Razmi T M; Hafi NAB
    Eur J Intern Med; 2020 Oct; 80():101-102. PubMed ID: 32651040
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine.
    Ibrahim H; Perl A; Smith D; Lewis T; Kon Z; Goldenberg R; Yarta K; Staniloae C; Williams M
    Clin Immunol; 2020 Oct; 219():108544. PubMed ID: 32707089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
    Sivapalan P; Ulrik CS; Bojesen RD; Lapperre TS; Eklöf JV; Håkansson KEJ; Browatzki A; Tidemansen C; Wilcke JT; Janner J; Gottlieb V; Meteran H; Porsbjerg C; Madsen BL; Moberg M; Pedersen L; Benfield TL; Lundgren JD; Knop FK; Biering-Sørensen T; Ghanizada M; Sonne TP; Bødtger UCS; Jensen SG; Rasmussen DB; Brøndum E; Tupper OD; Sørensen SW; Alstrup G; Laursen CB; Møller UW; Sverrild A; Jensen JS
    Trials; 2020 Jun; 21(1):513. PubMed ID: 32522282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemolytic Anemia in a Glucose-6-Phosphate Dehydrogenase-Deficient Patient Receiving Hydroxychloroquine for COVID-19: A Case Report.
    Aguilar J; Averbukh Y
    Perm J; 2020; 24():. PubMed ID: 33183501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infection.
    Giaime P; Guenoun M; Pedinielli N; Narbonne H; Bergounioux JP; Solas C; Guilhaumou R; Sampol J; Ollier J; Sichez H; Serveaux M; Brunner F; Bataille S
    Nephrol Dial Transplant; 2020 Aug; 35(8):1346-1353. PubMed ID: 32844224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Outcome of Hydroxychloroquine in Patients Treated for COVID-19: Systematic Review and Meta-Analysis.
    Ayele Mega T; Feyissa TM; Dessalegn Bosho D; Kumela Goro K; Zeleke Negera G
    Can Respir J; 2020; 2020():4312519. PubMed ID: 33082891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes?
    Mégarbane B; Scherrmann JM
    J Clin Pharmacol; 2020 Jul; 60(7):808-814. PubMed ID: 32434282
    [No Abstract]   [Full Text] [Related]  

  • 11. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case of COVID-19 in a Patient with Asymptomatic Hemoglobin D Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency.
    Sasi S; Yassin MA; Nair AP; Al Maslamani MS
    Am J Case Rep; 2020 Jul; 21():e925788. PubMed ID: 32697769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose-6-phosphate dehydrogenase deficiency associated hemolysis in COVID-19 patients treated with hydroxychloroquine/chloroquine: New case reports coming out.
    De Franceschi L; Costa E; Dima F; Morandi M; Olivieri O
    Eur J Intern Med; 2020 Oct; 80():103. PubMed ID: 32819797
    [No Abstract]   [Full Text] [Related]  

  • 14. Glucose-6-phosphate dehydrogenase deficiency and hydroxychloroquine in the COVID-19 era: a mini review.
    Onori ME; Ricciardi Tenore C; Urbani A; Minucci A
    Mol Biol Rep; 2021 Mar; 48(3):2973-2978. PubMed ID: 33620659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease.
    Satlin MJ; Goyal P; Magleby R; Maldarelli GA; Pham K; Kondo M; Schenck EJ; Rennert H; Westblade LF; Choi JJ; Safford MM; Gulick RM
    PLoS One; 2020; 15(7):e0236778. PubMed ID: 32701969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?
    Nina PB; Dash AP
    Indian J Public Health; 2020 Jun; 64(Supplement):S125-S127. PubMed ID: 32496241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methemoglobinemia in Patient with G6PD Deficiency and SARS-CoV-2 Infection.
    Palmer K; Dick J; French W; Floro L; Ford M
    Emerg Infect Dis; 2020 Sep; 26(9):2279-81. PubMed ID: 32579876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial.
    Furtado RHM; Berwanger O; Fonseca HA; Corrêa TD; Ferraz LR; Lapa MG; Zampieri FG; Veiga VC; Azevedo LCP; Rosa RG; Lopes RD; Avezum A; Manoel ALO; Piza FMT; Martins PA; Lisboa TC; Pereira AJ; Olivato GB; Dantas VCS; Milan EP; Gebara OCE; Amazonas RB; Oliveira MB; Soares RVP; Moia DDF; Piano LPA; Castilho K; Momesso RGRAP; Schettino GPP; Rizzo LV; Neto AS; Machado FR; Cavalcanti AB;
    Lancet; 2020 Oct; 396(10256):959-967. PubMed ID: 32896292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brief Report: Hydroxychloroquine does not induce hemolytic anemia or organ damage in a "humanized" G6PD A- mouse model.
    Zuchelkowski BE; Wang L; Gingras S; Xu Q; Yang M; Triulzi D; Page GP; Gordeuk VR; Kim-Shapiro DB; Lee JS; Gladwin MT
    PLoS One; 2020; 15(10):e0240266. PubMed ID: 33007039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute meningoencephalitis in a patient with COVID-19.
    Chaumont H; Etienne P; Roze E; Couratier C; Roger PM; Lannuzel A
    Rev Neurol (Paris); 2020 Jun; 176(6):519-521. PubMed ID: 32414534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.